Results from vaccine trials conducted in the US, South Africa and Brazil found its efficacy against the worst outcomes of the virus was “similarly high” but overall protection was lower in South Africa and Brazil, where virus variants have become dominant.
Click Here to Visit Orignal Source of Article https://www.bbc.co.uk/news/world-us-canada-56186965